As the five prognostic genes (ALDH3B1, EGFR, ERAP2, MSLN, and NCEH1) were highly expressed in gemcitabine-resistant PC cell lines, this established gene signature was, therefore, a very promising indicator of gemcitabine sensitivity for PC patients. The gene discussed is MSLN; the disease is pachyonychia congenita.